ArticleHuman cell2025
Activation of the circAGFG1/miR-195-5p/PD-L1 axis induces lung injury in sepsis.
Article in Human cell, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- S100A9 deletion ameliorates acute lung injury by attenuating excessive neutrophil activation via activating the NRF2/HO-1 signaling axis.Respiratory research · 2026Article
- Circular RNAs in sepsis-induced acute lung injury: emerging mechanisms and therapeutic potential.Frontiers in immunology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Severe sepsis can escalate to acute lung injury (ALI), a critical condition with limited treatment options. Emerging research highlights the role of non-coding RNAs, including microRNAs (miRNAs) and circular RNAs (circRNAs), in regulating epithelial and immune cell responses in sepsis-induced ALI. This study delves into the circAGFG1/miR-195-5p/PD-L1 axis to elucidate its potential in this context. The conducted experiments using Th17 cells differentiated from CD4+ T cells isolated from human umbilical cord blood, co-cultured with transfected Calu-3 cells. The assessed cell viability, RNA, and protein expression levels under inflammatory stimuli. In addition, we collected bronchoalveolar lavage fluid and lung tissues from a cecal ligation and puncture mouse model. Quantification of RNA and protein expression of inflammatory and survival markers provided insights into the regulatory mechanisms involved. Peripheral blood samples from sepsis/ALI patients and healthy controls revealed that circAGFG1 expression is significantly downregulated, while miR-195-5p expression is upregulated in patients compared to healthy individuals. In both Calu-3 cells and induced Th17 cells, as well as in sepsis-induced ALI mouse models, the circAGFG1/miR-195-5p/PD-L1 axis was shown to regulate the expression of inflammatory cytokines, Th17 cell differentiation, and markers of epithelial cell survival. Results show the circAGFG1/miR-195-5p/PD-L1 axis plays a critical role in the pathogenesis of sepsis-induced ALI. Targeting this axis could present a novel therapeutic strategy for preventing ALI in sepsis and other conditions characterized by heightened lung inflammation. This research paves the way for new treatment approaches, offering hope for improved outcomes in patients suffering from severe sepsis and ALI.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.